Advances in recurrent stroke prevention: focus on antithrombotic therapies
B Mac Grory, S Yaghi, C Cordonnier… - Circulation …, 2022 - Am Heart Assoc
The past decade has seen significant advances in stroke prevention. These advances
include new antithrombotic agents, new options for dyslipidemia treatment, and novel …
include new antithrombotic agents, new options for dyslipidemia treatment, and novel …
Pharmacotherapy for stroke prevention in nonvalvular atrial fibrillation: current strategies and future directions
A Gómez-Outes, ML Suárez-Gea… - Expert Opinion on …, 2022 - Taylor & Francis
Introduction Cardioembolic stroke, associated to nonvalvular atrial fibrillation (NVAF),
accounts for approximately one in every four strokes. Cardioembolic stroke has a bad …
accounts for approximately one in every four strokes. Cardioembolic stroke has a bad …
Apixaban versus rivaroxaban in patients with atrial fibrillation and valvular heart disease: a population-based study
Background: Although apixaban and rivaroxaban are commonly used in patients with atrial
fibrillation (AF) and valvular heart disease (VHD), there is limited evidence comparing the 2 …
fibrillation (AF) and valvular heart disease (VHD), there is limited evidence comparing the 2 …
Direct oral anticoagulants versus warfarin in patients with atrial fibrillation and valve replacement or repair
Background We sought to examine outcomes of direct oral anticoagulants (DOACs) versus
warfarin in atrial fibrillation with valve repair/replacement. Methods and Results Two atrial …
warfarin in atrial fibrillation with valve repair/replacement. Methods and Results Two atrial …
Time trends in patient characteristics, anticoagulation treatment, and prognosis of incident nonvalvular atrial fibrillation in the Netherlands
Q Chen, MMA Toorop, LF Tops, WM Lijfering… - JAMA Network …, 2023 - jamanetwork.com
Importance The temporal trend in adverse events regarding stroke prevention for
nonvalvular atrial fibrillation (NVAF) in the direct oral anticoagulant (DOAC) era was rarely …
nonvalvular atrial fibrillation (NVAF) in the direct oral anticoagulant (DOAC) era was rarely …
Risk of hospitalization for upper gastrointestinal bleeding in Helicobacter pylori eradicated patients newly started on warfarin or direct oral anticoagulants: A …
Background To investigate risks of hospitalization for upper gastrointestinal bleeding (UGIB)
in H. pylori‐eradicated patients newly started on warfarin or direct oral anti‐coagulants …
in H. pylori‐eradicated patients newly started on warfarin or direct oral anti‐coagulants …
XGBoost-based machine learning test improves the accuracy of hemorrhage prediction among geriatric patients with long-term administration of rivaroxaban
C Chen, C Yin, Y Wang, J Zeng, S Wang, Y Bao, Y Xu… - BMC geriatrics, 2023 - Springer
Background Hemorrhage is a potential and serious adverse drug reaction, especially for
geriatric patients with long-term administration of rivaroxaban. It is essential to establish an …
geriatric patients with long-term administration of rivaroxaban. It is essential to establish an …
Active surveillance pharmacovigilance for Clostridioides difficile infection and gastrointestinal bleeding: an analytic framework based on case-control studies
RK Vajravelu, AR Byerly, R Feldman… - Ebiomedicine, 2024 - thelancet.com
Background Active surveillance pharmacovigilance is an emerging approach to identify
medications with unanticipated effects. We previously developed a framework called …
medications with unanticipated effects. We previously developed a framework called …
Gastrointestinal bleeding on oral anticoagulation: what is currently known
Gastrointestinal bleeding (GIB) is the most common type of bleeding occurring in patients on
oral anticoagulation. A meta-analysis of the landmark randomized controlled trials (RCTs) …
oral anticoagulation. A meta-analysis of the landmark randomized controlled trials (RCTs) …
What you need to know about migraine in Hughes syndrome patients
JR Schofield, KL Hassell - Lupus, 2023 - journals.sagepub.com
Background Headache, often migrainous, is common in patients with antiphospholipid
antibodies, whether or not they meet Sydney criteria for a definite diagnosis of Hughes …
antibodies, whether or not they meet Sydney criteria for a definite diagnosis of Hughes …